Ontology highlight
ABSTRACT:
SUBMITTER: Vivet-Boudou V
PROVIDER: S-EPMC3210175 | biostudies-literature | 2011
REPOSITORIES: biostudies-literature
Vivet-Boudou Valérie V Isel Catherine C Sleiman Marwan M Smyth Redmond R Ben Gaied Nouha N Barhoum Patrick P Laumond Géraldine G Bec Guillaume G Götte Matthias M Mak Johnson J Aubertin Anne-Marie AM Burger Alain A Marquet Roland R
PloS one 20111107 11
The occurrence of resistant viruses to any of the anti-HIV-1 compounds used in the current therapies against AIDS underlies the urge for the development of new drug targets and/or new drugs acting through novel mechanisms. While all anti-HIV-1 nucleoside analogues in clinical use and in clinical trials rely on ribose modifications for activity, we designed nucleosides with a natural deoxyribose moiety and modifications of position 8 of the adenine base. Such modifications might induce a steric c ...[more]